Synapse - Breast Medicine Service

Results (4181)

Germline pathogenic variants impact clinicopathology of advanced lung cancer

Journal Article

Mukherjee, S.; Bandlamudi, C.; Hellmann, M. D.; Kemel, Y.; Drill, E.; Rizvi, H.; Tkachuk, K.; Khurram, A.; Walsh, M. F.; Zauderer, M. G.; more...
Cancer Epidemiology Biomarkers and Prevention (2022)

Fulltext@MSK | Save

ASO Visual Abstract: Comparison of outcomes between BRCA pathogenic variant carriers undergoing breast-conserving surgery and those treated with mastectomy

Miscellaneous

Shubeck, S.; Sevilimedu, V.; Berger, E.; Robson, M.; Heerdt, A. S.; Pilewskie, M. L.
Annals of Surgical Oncology (2022)

Fulltext@MSK | Save

Alpelisib (ALP) + endocrine therapy (ET) in patients (pts) with PIK3CA-mutated, hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Subgroup analyses from the BYLieve study

Meeting Abstract

Cardoso, F.; Juric, D.; Lerebours, F.; Krop, I.; Ruiz Borrego, M.; Neven, P.; Park, Y. H.; Yardley, D.; Jhaveri, K.; Arce, C.; more...
Annals of Oncology (2022)

Fulltext@MSK | Save

Perspectives in immunotherapy: Meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021

Review

Ascierto, P. A.; Avallone, A.; Bhardwaj, N.; Bifulco, C.; Bracarda, S.; Brody, J. D.; Buonaguro, L.; Demaria, S.; Emens, L. A.; Ferris, R. L.; more...
Journal of Translational Medicine (2022)

Fulltext@MSK | Save

Effects of patient-reported outcome assessment order

Journal Article

Novotny, P.J.; Dueck, A. C.; Satele, D.; Frost, M. H.; Beebe, T. J.; Yost, K. J.; Lee, M. K.; Eton, D. T.; Yount, S.; Cella, D.; more...
Clinical Trials (2022)

Fulltext@MSK | Save

BERENICE final analysis: Cardiac safety study of neoadjuvant pertuzumab, trastuzumab, and chemotherapy followed by adjuvant pertuzumab and trastuzumab in HER2-positive early breast cancer